Is Kyndryl Holdings KD stock forming a breakout pattern Q1 2026 EPS Misses Estimates Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus ATON AlphaTON reports Q2 2025 EPS of negative 126 shares trade flat with no prior analyst estimates